1-20 of 180
Sort by
News

A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T, NCT04161885)

Lara C. Pullen, PhD
Published: 2025
Abstract
April 2025
View News titled, A Study Evaluating Safety and Efficacy of Venetoclax in Combination With Azacitidine Versus Standard of Care After Allogeneic Stem Cell Transplantation (SCT) in Participants With Acute Myeloid Leukemia (AML) (VIALE-T, NCT04161885)
News

Obecabtagene Autoleucel Effective Treatment for Adults with B-ALL

Lara C. Pullen, PhD
Published: 2025
Abstract
March 2025
View News titled, Obecabtagene Autoleucel Effective Treatment for Adults with B-ALL
News

CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study

Katie Robinson
Published: 2025
Abstract
February 2025
View News titled, CAR-T Shows Acceptable Efficacy, Safety in Phase II R/R T-ALL/LBL Study
News

Predicting Response to Obe-Cel in Patients With R/R B-ALL

Lara C. Pullen, PhD
Published: 2025
Abstract
February 2025
View News titled, Predicting Response to Obe-Cel in Patients With R/R B-ALL
News

Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study

Anna Azvolinsky, PhD
Published: 2025
Abstract
February 2025
View News titled, Combination of Venetoclax, Lower Intensity CPX-351 Shows Positive Results in Early-Stage AML Study
News

New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, New Risk Classification Stratifies Outcomes in Older Intensively Treated Patients with AML
News

Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Weekly Low-Dose Regimen of Decitabine and Venetoclax as Effective as Higher Dose
News

Geriatric Assessment-Guided Conditioning Reduced Non-Relapse Mortality for Transplant in Myeloid Malignancies

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, Geriatric Assessment-Guided Conditioning Reduced Non-Relapse Mortality for Transplant in Myeloid Malignancies
News

Addition of Induction Gilteritinib May Provide Some Benefit for Newly Diagnosed FLT3-Mutated AML

Leah Lawrence
Published: 2024
Abstract
January 2025
View News titled, Addition of Induction Gilteritinib May Provide Some Benefit for Newly Diagnosed FLT3-Mutated AML
News

Socioeconomic Factors, Education Levels Affect Access to AlloHCT for AML

Lara C. Pullen, PhD
Published: 2024
Abstract
January 2025
View News titled, Socioeconomic Factors, Education Levels Affect Access to AlloHCT for AML
News

Blinatumomab Added to Chemotherapy Is New Standard of Care in Newly Diagnosed Childhood SR B-ALL

Khylia Marshall
Published: 2024
Abstract
January 2025
View News titled, Blinatumomab Added to Chemotherapy Is New Standard of Care in Newly Diagnosed Childhood SR B-ALL
News

Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib

Lara C. Pullen, PhD
Published: 2024
Abstract
December 2024
View News titled, Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Respond Well to Asciminib, Dasatinib
News

Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests

Thomas R. Collins
Published: 2024
Abstract
Mid-November 2024
View News titled, Venetoclax Effective for Bridging to Transplant in R/R AML, Study Suggests
News

Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine

Anna Azvolinsky, PhD
Published: 2024
Abstract
November 2024
View News titled, Genetics-Based Risk Model to Stratify Survival Outcomes of Patients With AML Treated With Venetoclax-Azacitidine
News

Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?

Leah Lawrence
Published: 2024
Abstract
October 2024
View News titled, Drawing First Blood: Will Menin Inhibitors Revolutionize the Treatment of AML?
News

Study Examines Development of Paraparesis, Quadriparesis in Pediatric Patients With B-ALL Treated With CAR T-Cell Therapy

Anna Azvolinsky, PhD
Published: 2024
Abstract
September 2024
View News titled, Study Examines Development of Paraparesis, Quadriparesis in Pediatric Patients With B-ALL Treated With CAR T-Cell Therapy
News

Dose-Adjusted VEN-HMA Regimens Safe, Effective in Very Old Patients With AML

Leah Lawrence
Published: 2024
Abstract
August 2024
View News titled, Dose-Adjusted VEN-HMA Regimens Safe, Effective in Very Old Patients With AML
News

Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases

Thomas R. Collins
Published: 2024
Abstract
Mid-July 2024
View News titled, Straight-to-Transplantation Approach Comparable to Remission Induction in Difficult Acute Myeloid Leukemia Cases
News

ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia

Khylia Marshall
Published: 2024
Abstract
Mid-July 2024
View News titled, ATRA-ATO Regimen Demonstrates Superior EFS in Newly Diagnosed, High-Risk Acute Promyelocytic Leukemia
News

Which Inhibitor Should Be Used to Treat FLT3-Positive AML?

Emma Yasinski
Published: 2024
Abstract
July 2024
View News titled, Which Inhibitor Should Be Used to Treat FLT3-Positive AML?